Condition | Medications |
---|---|
Circulatory system | Â |
Heart failure | Non-COX-2 selective NSAIDs, COX-2 selective NSAIDs, thiazolidinediones, non-dihydropyridine calcium channel blockers (diltiazem, verapamil), digoxin, tricyclic antidepressants, sildenafil, tadalafil, vardenafil |
Syncope | Donepezil, rivastigmine, galantamine, non-selective alpha-blockers, tricyclic antidepressants, benzodiazepines, antipsychotics, methyldopa, venlafaxine |
Bradycardia | Beta-blockers, donepezil, rivastigmine, galantamine, non-dihydropyridine calcium channel blockers |
Arrythmias | Antiarrhythmics, tricyclic antidepressants, antipsychotics, donepezil, quinine |
Hypertension | Loop diuretics, non-selective alpha blockers, NSAIDs, thiazides, methyldopa |
Hypertension and urinary incontinence | Loop diuretics |
Dependent ankle oedema | Loop diuretics, calcium channel blockers |
Hypokalemia | Thiazide, digoxin, fludrocortisone, loop diuretics, |
Hyponatremia | Thiazides, selective serotonin reuptake inhibitors |
Hypercalcemia | Thiazides |
Hyperkalemia | ACE inhibitors, ARBs, spironolactone |
High bleeding risk (e.g., coagulopathy) | Antiplatelet, vitamin K antagonists, direct thrombin inhibitors, direct factor Xa inhibitors, NSAIDs |
First deep vein thrombosis (without continuing risks) | Vitamin K antagonists, direct thrombin inhibitors, direct factor Xa inhibitors |
Cardiac conduction abnormalities and heart block | Tricyclic antidepressants, digoxin, verapamil, amiodarone, acetylcholinesterase inhibitors (e.g., donepezil, rivastigmine), beta blockers |
Orthostatic hypotension | Non-selective alpha blockers, calcium channel blockers, long-acting nitrates, chlorpromazine, tricyclic antidepressants, hydralazine, thiazide, loop diuretics, dopamine agonists (except levodopa), selegiline, antipsychotics, SGLT-2 inhibitors |
Acute coronary symptoms | COX-2 selective NSAIDs, Non-COX-2 selective NSAIDS |
Raynaud disease | Beta-blockers |
Nervous system | Â |
Delirium, dementia or cognitive impairment | Urological spasmolytic (e.g., oxybutynin, tolterodine), first-generation antihistamines, antiparkinsonian drugs, antiemetics, muscle relaxants (e.g., orphenadrine), tricyclic antidepressants, paroxetine, antipsychotics, disopyramide, intestinal antispasmodics (e.g., atropine, scopolamine), psychostimulants (methylphenidate), barbiturates, benzodiazepines, zolpidem, deferoxamine, testosterone, corticosteroids, dopamine agonist, antiepileptics |
History of falls or fractures | Antipsychotics, benzodiazepines, zolpidem, opioids, tricyclic antidepressants, antiepileptics (e.g., carbamazepine, phenytoin), first generation antihistamines, non-selective alpha blockers, non-selective beta-blockers, paroxetine, duloxetine, loop diuretics |
Parkinson disease and Parkinsonism | Antipsychotics (except quetiapine, clozapine), antiemetics (e.g., prochlorperazine, promethazine, metoclopramide), benzhexol |
Behavioral and psychological symptoms in dementia | Antipsychotics, anticonvulsants, benzodiazepines |
Sleep disorders or insomnia | Antipsychotics, psychostimulants (e.g., methylphenidate, caffeine), theophylline, pseudoephedrine, benzodiazepines (temazepam could be considered for short-term use), barbiturates, tricyclic antidepressants, Z-hypnotics |
Benign essential tremor | Levodopa and dopamine agonists, benzhexol |
Depression | Centrally acting antihypertensives (e.g., methyldopa, reserpine), tricyclic antidepressant |
Seizures or epilepsy | Antipsychotics, bupropion, antidepressants, beta-lactam antibiotics, theophylline, H2 antagonists, levodopa, isoniazid, opioids |
Gastrointestinal system | Â |
History of gastric or duodenal ulcers | Aspirin, Non-COX-2 Selective NSAIDs, Corticosteroids |
History of esophageal ulcers and dysphagia | Oral bisphosphonates |
Constipation | Drugs with anticholinergics properties, verapamil, oral iron, opioids, aluminium antacids, tricyclic antidepressants, calcium supplements, diuretics |
Genitourinary system | Â |
Chronic kidney disease | Non-COX-2 selective NSAIDs, COX-2 selective NSAIDs, glibenclamide, digoxin, dabigatran, metformin, oral bisphosphonates, colchicine, thiazide, factor Xa inhibitors, donepezil, memantine, cimetidine, ciprofloxacin, gabapentin, PPI, ACEI, ARBs, warfarin, allopurinol, opioids, aminoglycosides, amphotericin B, vancomycin, acyclovir, clopidogrel, ticlopidine |
Benign prostatic hyperplasia | Strong anticholinergic drugs, tricyclic antidepressants, antimuscarinic bronchodilators (e.g., ipratropium, tiotropium) |
Urinary incontinence | Non-selective alpha blockers, tricyclic antidepressants, diuretics |
Respiratory system | Â |
Bronchial asthma | Non-selective beta blockers, benzodiazepines |
Chronic obstructive pulmonary disease | Theophylline, non-selective beta-blockers, benzodiazepines |
Acute or chronic respiratory failures | Benzodiazepines, opioids, alcohol, cocaine, amphetamines |
Sleep apnea | Benzodiazepines |
Other systems | Â |
Narrow angle glaucoma | Tricyclic antidepressants, antimuscarinic bronchodilators, strongly anticholinergic drugs, Urological spasmolytic (e.g., oxybutynin) |
Osteoarthritis and osteoporosis | Systemic corticosteroids (except intra-articular), high dose calcium supplements, NSAIDs, eperisone |
Pain | Opioids in chronic mild pain, long-acting opioids without short-acting opioids in breakthrough pain, benzodiazepines, tramadol |
Gout | Loop diuretics, colchicine |
Diabetes mellitus | Beta blockers, corticosteroids, olanzapine, quetiapine, risperidone |
Breast cancer | Oestrogens |
Venous thromboembolism | Oestrogens |